Is there hope for digital health startups post-Roe?

Equity

This is our Wednesday show, where we niche down to a single topic, think about a question and unpack the rest. This week, Natasha asked: How do digital health startups build in a post-Roe world?

The question comes after Natasha’s recent Startups Weekly column, "When your startup’s core mission is set to be overturned." The piece explores the ripple effects of the looming Roe v. Wade overturn, specifically in how it impacts startups. But, let's not hypothesize. We brought on Kiki Freedman, the CEO and co-founder of Hey Jane, to answer our big questions about building, raising, and existing when so much regulatory scrutiny is weighing on your business. A direct-to-consumer health company that specializes in the delivery of abortion pills, Hey Jane about to kick off its fundraising process which makes for an interesting tension. The startup - especially today - really sits in the middle of two intense moments: an overturn to Roe v. Wade would threaten all of its work, and a toughening, risk-averse VC market could be a hurdle toward next financing.

Enjoy the show, and let us know if you like this interview format. Also, here's the Found interview that we referenced during the show as well!

Credits: Equity is hosted by TechCrunch's Alex Wilhelm and Mary Ann Azevedo. We are produced by Theresa Loconsolo with editing by Kell. Bryce Durbin is our Illustrator. We'd also like to thank the audience development team and Henry Pickavet, who manages TechCrunch audio products.